Global Genomic Cancer Testing Market Research Report 2025
- Published Date: 2024-12-19
- Report ID: 9166769
- Pages: 200
-
Format:
Report Overview
This report provides a deep insight into the global Genomic Cancer Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Genomic Cancer Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Genomic Cancer Testing market in any manner.
Global Genomic Cancer Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Market Segmentation (by Type)
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Market Segmentation (by Application)
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Genomic Cancer Testing Market
Overview of the regional outlook of the Genomic Cancer Testing Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Genomic Cancer Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Genomic Cancer Testing
1.2 Key Market Segments
1.2.1 Genomic Cancer Testing Segment by Type
1.2.2 Genomic Cancer Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Genomic Cancer Testing Market Overview
2.1 Global Market Overview
2.1.1 Global Genomic Cancer Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Genomic Cancer Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Genomic Cancer Testing Market Competitive Landscape
3.1 Global Genomic Cancer Testing Sales by Manufacturers (2019-2024)
3.2 Global Genomic Cancer Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Genomic Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Genomic Cancer Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Genomic Cancer Testing Sales Sites, Area Served, Product Type
3.6 Genomic Cancer Testing Market Competitive Situation and Trends
3.6.1 Genomic Cancer Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Genomic Cancer Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Genomic Cancer Testing Industry Chain Analysis
4.1 Genomic Cancer Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Genomic Cancer Testing Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Genomic Cancer Testing Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Genomic Cancer Testing Sales Market Share by Type (2019-2024)
6.3 Global Genomic Cancer Testing Market Size Market Share by Type (2019-2024)
6.4 Global Genomic Cancer Testing Price by Type (2019-2024)
7 Genomic Cancer Testing Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Genomic Cancer Testing Market Sales by Application (2019-2024)
7.3 Global Genomic Cancer Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Genomic Cancer Testing Sales Growth Rate by Application (2019-2024)
8 Genomic Cancer Testing Market Segmentation by Region
8.1 Global Genomic Cancer Testing Sales by Region
8.1.1 Global Genomic Cancer Testing Sales by Region
8.1.2 Global Genomic Cancer Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Genomic Cancer Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Genomic Cancer Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Genomic Cancer Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Genomic Cancer Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Genomic Cancer Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Devyser
9.1.1 Devyser Genomic Cancer Testing Basic Information
9.1.2 Devyser Genomic Cancer Testing Product Overview
9.1.3 Devyser Genomic Cancer Testing Product Market Performance
9.1.4 Devyser Business Overview
9.1.5 Devyser Genomic Cancer Testing SWOT Analysis
9.1.6 Devyser Recent Developments
9.2 Agendia
9.2.1 Agendia Genomic Cancer Testing Basic Information
9.2.2 Agendia Genomic Cancer Testing Product Overview
9.2.3 Agendia Genomic Cancer Testing Product Market Performance
9.2.4 Agendia Business Overview
9.2.5 Agendia Genomic Cancer Testing SWOT Analysis
9.2.6 Agendia Recent Developments
9.3 Illumina
9.3.1 Illumina Genomic Cancer Testing Basic Information
9.3.2 Illumina Genomic Cancer Testing Product Overview
9.3.3 Illumina Genomic Cancer Testing Product Market Performance
9.3.4 Illumina Genomic Cancer Testing SWOT Analysis
9.3.5 Illumina Business Overview
9.3.6 Illumina Recent Developments
9.4 Personal Genome Diagnostics
9.4.1 Personal Genome Diagnostics Genomic Cancer Testing Basic Information
9.4.2 Personal Genome Diagnostics Genomic Cancer Testing Product Overview
9.4.3 Personal Genome Diagnostics Genomic Cancer Testing Product Market Performance
9.4.4 Personal Genome Diagnostics Business Overview
9.4.5 Personal Genome Diagnostics Recent Developments
9.5 Veracyte
9.5.1 Veracyte Genomic Cancer Testing Basic Information
9.5.2 Veracyte Genomic Cancer Testing Product Overview
9.5.3 Veracyte Genomic Cancer Testing Product Market Performance
9.5.4 Veracyte Business Overview
9.5.5 Veracyte Recent Developments
9.6 Pacific Biosciences of California
9.6.1 Pacific Biosciences of California Genomic Cancer Testing Basic Information
9.6.2 Pacific Biosciences of California Genomic Cancer Testing Product Overview
9.6.3 Pacific Biosciences of California Genomic Cancer Testing Product Market Performance
9.6.4 Pacific Biosciences of California Business Overview
9.6.5 Pacific Biosciences of California Recent Developments
9.7 Qiagen
9.7.1 Qiagen Genomic Cancer Testing Basic Information
9.7.2 Qiagen Genomic Cancer Testing Product Overview
9.7.3 Qiagen Genomic Cancer Testing Product Market Performance
9.7.4 Qiagen Business Overview
9.7.5 Qiagen Recent Developments
9.8 Agilent Technologies
9.8.1 Agilent Technologies Genomic Cancer Testing Basic Information
9.8.2 Agilent Technologies Genomic Cancer Testing Product Overview
9.8.3 Agilent Technologies Genomic Cancer Testing Product Market Performance
9.8.4 Agilent Technologies Business Overview
9.8.5 Agilent Technologies Recent Developments
9.9 Natera
9.9.1 Natera Genomic Cancer Testing Basic Information
9.9.2 Natera Genomic Cancer Testing Product Overview
9.9.3 Natera Genomic Cancer Testing Product Market Performance
9.9.4 Natera Business Overview
9.9.5 Natera Recent Developments
9.10 Bio Rad Laboratories
9.10.1 Bio Rad Laboratories Genomic Cancer Testing Basic Information
9.10.2 Bio Rad Laboratories Genomic Cancer Testing Product Overview
9.10.3 Bio Rad Laboratories Genomic Cancer Testing Product Market Performance
9.10.4 Bio Rad Laboratories Business Overview
9.10.5 Bio Rad Laboratories Recent Developments
9.11 Myriad Genetics
9.11.1 Myriad Genetics Genomic Cancer Testing Basic Information
9.11.2 Myriad Genetics Genomic Cancer Testing Product Overview
9.11.3 Myriad Genetics Genomic Cancer Testing Product Market Performance
9.11.4 Myriad Genetics Business Overview
9.11.5 Myriad Genetics Recent Developments
10 Genomic Cancer Testing Market Forecast by Region
10.1 Global Genomic Cancer Testing Market Size Forecast
10.2 Global Genomic Cancer Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Genomic Cancer Testing Market Size Forecast by Country
10.2.3 Asia Pacific Genomic Cancer Testing Market Size Forecast by Region
10.2.4 South America Genomic Cancer Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Genomic Cancer Testing by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Genomic Cancer Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Genomic Cancer Testing by Type (2025-2030)
11.1.2 Global Genomic Cancer Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Genomic Cancer Testing by Type (2025-2030)
11.2 Global Genomic Cancer Testing Market Forecast by Application (2025-2030)
11.2.1 Global Genomic Cancer Testing Sales (K Units) Forecast by Application
11.2.2 Global Genomic Cancer Testing Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
